- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kobayashi Pharmaceutical Co Ltd (4967)
Kobayashi Pharmaceutical Co Ltd stock price live, this page displays TYO 4967 stock exchange data. View the 4967 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kobayashi Pharmaceutical Co Ltd real time stock price chart below.
What Is the Kobayashi Pharmaceutical Co Ltd Stock Price Today?
The Kobayashi Pharmaceutical Co Ltd stock price today is 5,492.0.
What Is the Stock Symbol for Kobayashi Pharmaceutical Co Ltd?
The stock symbol for Kobayashi Pharmaceutical Co Ltd is "4967."
What Stock Exchange Does Kobayashi Pharmaceutical Co Ltd Trade On?
Kobayashi Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Kobayashi Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Kobayashi Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4967 quote. (ISIN: JP3301100008)
What Is the Kobayashi Pharmaceutical Co Ltd Stock Price Today?
The Kobayashi Pharmaceutical Co Ltd stock price today is 5,492.0.
What Is the Stock Symbol for Kobayashi Pharmaceutical Co Ltd?
The stock symbol for Kobayashi Pharmaceutical Co Ltd is "4967."
What Stock Exchange Does Kobayashi Pharmaceutical Co Ltd Trade On?
Kobayashi Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Kobayashi Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Kobayashi Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4967 quote. (ISIN: JP3301100008)
5,492.0
+75.0(+1.38%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5,307.0
5,539.0
52 wk Range
4,850.0
5,885.0
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5,307.05,539.0
52 wk Range
4,850.05,885.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.89%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.89%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4967 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
5,501.4
Upside
+0.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 8 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Kobayashi Pharmaceutical Co Ltd Company Profile
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, sanitary and paper products, hand warmers, aloe products, displays, models, mouthpieces, and kaiko; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, and asset management activities. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Compare 4967 to Peers and Sector
Metrics to compare | 4967 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship4967PeersSector | |
|---|---|---|---|---|
P/E Ratio | 110.2x | 19.9x | 12.4x | |
PEG Ratio | −1.73 | 0.35 | 0.03 | |
Price/Book | 1.9x | 1.8x | 1.5x | |
Price / LTM Sales | 2.4x | 1.6x | 0.9x | |
Upside (Analyst Target) | −3.9% | 6.5% | 16.1% | |
Fair Value Upside | Unlock | 11.3% | 10.7% | Unlock |
Analyst Ratings
2 Buy
4 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 5,501.4
(+0.17% Upside)
Earnings
Latest Release
Feb 10, 2026
EPS / Forecast
-42.41 / 81.80
Revenue / Forecast
53.70B / 53.46B
People Also Watch
FAQ
What Is the Kobayashi Pharmaceutical (4967) Stock Price Today?
The Kobayashi Pharmaceutical stock price today is 5,492.0
What Stock Exchange Does Kobayashi Pharmaceutical Trade On?
Kobayashi Pharmaceutical is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Kobayashi Pharmaceutical?
The stock symbol for Kobayashi Pharmaceutical is "4967."
Does Kobayashi Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Kobayashi Pharmaceutical dividend yield is 1.89%.
What Is the Kobayashi Pharmaceutical Market Cap?
As of today, Kobayashi Pharmaceutical market cap is 408.27B.
What Is Kobayashi Pharmaceutical's Earnings Per Share (TTM)?
The Kobayashi Pharmaceutical EPS (TTM) is 49.18.
When Is the Next Kobayashi Pharmaceutical Earnings Date?
Kobayashi Pharmaceutical will release its next earnings report on May 08, 2026.
From a Technical Analysis Perspective, Is 4967 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Kobayashi Pharmaceutical Stock Split?
Kobayashi Pharmaceutical has split 3 times.
How Many Employees Does Kobayashi Pharmaceutical Have?
Kobayashi Pharmaceutical has 3615 employees.
What is the current trading status of Kobayashi Pharmaceutical (4967)?
As of Feb 12, 2026, Kobayashi Pharmaceutical (4967) is trading at a price of 5,492.0, with a previous close of 5,417.0. The stock has fluctuated within a day range of 5,307.0 to 5,539.0, while its 52-week range spans from 4,850.0 to 5,885.0.
What Is Kobayashi Pharmaceutical (4967) Price Target According to Analysts?
The average 12-month price target for Kobayashi Pharmaceutical is JPY5,501.4, with a high estimate of JPY6700 and a low estimate of JPY4900. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +0.17% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.